
The Pennsylvania attorney general has dropped his opposition to Jefferson Health’s acquisition of Einstein Healthcare Network, according to The Philadelphia Inquirer.
The decision to drop his challenge comes after the Federal Trade Commission lost its latest attempt to prevent the merger and Jefferson agreed to invest $200 million into Einstein’s Philadelphia hospitals.
“Following extensive talks with Jefferson and Einstein, the systems have committed to making investments in North Philadelphia that will go beyond what was initially proposed and are especially crucial while we face this global health pandemic,” the attorney general’s office told the Inquirer.
The FTC and the Pennsylvania attorney general’s office sued last February to block the transaction. They argued the combination of the two systems, which comprise 17 hospitals, would reduce competition in Philadelphia and Montgomery counties, resulting in price increases.
The US District Court for the Eastern District of Pennsylvania rejected the FTC and attorney general’s argument Dec. 8. The next day the FTC filed a motion for an emergency injunction pending an appeal, arguing the health systems will not be injured by temporarily delaying the transaction during the legal process. On Dec. 21, a panel of three judges from the 3rd Circuit Court of Appeals denied the FTC’s request to stay the merger.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Live Nation Under Criminal Antitrust Investigation Over Pandemic-Era Refund Policies
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas